General Information of Drug Formulation (ID: F07201)

Formulation Name
Eltrombopag 75 mg tablet
Company
GlaxoSmithKline; Novartis Pharmaceuticals Corporation
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Eltrombopag DMOGFIX Thrombocytopenia 3B64 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Eisenoxyd E00585 56841934 Colorant
Ferrosoferric oxide E00231 14789 Colorant
Magnesium stearate E00208 11177 lubricant
Mannitol E00103 6251 Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Polyethylene glycol 400 E00653 Not Available Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent